These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3005435)

  • 1. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
    Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
    J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of prototype live hepatitis A virus vaccines in primate models.
    Karron RA; Daemer R; Ticehurst J; D'Hondt E; Popper H; Mihalik K; Phillips J; Feinstone S; Purcell RH
    J Infect Dis; 1988 Feb; 157(2):338-45. PubMed ID: 2826614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings.
    André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S160-8. PubMed ID: 1335652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of secretory immunity in hepatitis A virus infection.
    Stapleton JT; Lange DK; LeDuc JW; Binn LN; Jansen RW; Lemon SM
    J Infect Dis; 1991 Jan; 163(1):7-11. PubMed ID: 1845810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neutralizing antibody response to hepatitis A virus.
    Lemon SM; Binn LN
    J Infect Dis; 1983 Dec; 148(6):1033-9. PubMed ID: 6317766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
    Sjogren MH; Purcell RH; McKee K; Binn L; Macarthy P; Ticehurst J; Feinstone S; Caudill J; See A; Hoke C
    Vaccine; 1992; 10 Suppl 1():S135-7. PubMed ID: 1335645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evaluation of a live hepatitis A vaccine in marmosets.
    Provost PJ; Banker FS; Wadsworth CW; Krah DL
    J Med Virol; 1991 Aug; 34(4):227-31. PubMed ID: 1658214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous vaccination for hepatitis A and B.
    Flehmig B; Heinricy U; Pfisterer M
    J Infect Dis; 1990 May; 161(5):865-8. PubMed ID: 2157770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production, quality control and characterization of an inactivated hepatitis A vaccine.
    Peetermans J
    Vaccine; 1992; 10 Suppl 1():S99-101. PubMed ID: 1335671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers.
    Kusov YuYu ; Elbert LB; Nelga IV; Grishina GK; Dunaevski OA; Kharin NV; Maslov YuN ; Drozdov SG; Balayan MS
    Vaccine; 1991 Aug; 9(8):540-1. PubMed ID: 1663301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination against hepatitis A].
    Giusti G; Russo M
    Recenti Prog Med; 1992 Jun; 83(6):313-20. PubMed ID: 1323136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immunogenicity of a cultured inactivated hepatitis A vaccine].
    Kusov IuIu; El'bert LB; Kazachkov IuA; Val'iano NM; Nel'ga IV; Grishina GK; Krutianskaia GL; Lisitsyna EA; Poleshchuk VF; Sobol' AV
    Vopr Virusol; 1991; 36(3):206-9. PubMed ID: 1654007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of hepatitis A by inactivated vaccines: unanswered questions and unresolved issues.
    Purcell RH
    J Hepatol; 1993; 18 Suppl 2():S61-4. PubMed ID: 8182277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental models of hepatitis A in macaques using viral strains isolated from man and monkeys].
    Korzaia LI; Esvandzhiia NCh; Lomovskaia IB; Krylova RI; Shevtsova ZV
    Mikrobiol Z; 1994; 56(1):22-9. PubMed ID: 8087252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.
    Mao JS; Dong DX; Zhang HY; Chen NL; Zhang XY; Huang HY; Xie RY; Zhou TJ; Wan ZJ; Wang YZ
    J Infect Dis; 1989 Apr; 159(4):621-4. PubMed ID: 2538518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.